ADORA2B and pancreatic neoplasm: Studies using human or murine organoid cultures and genetic deletion of Adora2b or pharmacologic inhibition will aid in scientific understanding of the mechanistic consequences of Adora2b expression in pancreatic cancer and also help determine if different PDAC subtypes respond differently to Adora2b inhibition.